nisoldipine has been researched along with Hibernation, Myocardial in 4 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nisoldipine was found to improve both left ventricular systolic and diastolic function without activating the adrenergic system." | 2.39 | Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. ( Marini, A; Sheiban, I; Tonni, S; Trevi, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheiban, I | 1 |
| Tonni, S | 1 |
| Marini, A | 1 |
| Trevi, G | 1 |
| Park, SW | 1 |
| Tang, XL | 1 |
| Qiu, Y | 1 |
| Sun, JZ | 1 |
| Bolli, R | 1 |
| Brunelli, C | 1 |
| Parodi, O | 1 |
| Sambuceti, G | 1 |
| Corsiglia, L | 1 |
| Spallarossa, P | 1 |
| Rosa, GM | 1 |
| Giorgetti, A | 1 |
| Bezante, GP | 1 |
| Nista, N | 1 |
| Caponnetto, S | 1 |
| Ehring, T | 1 |
| Heusch, G | 1 |
2 reviews available for nisoldipine and Hibernation, Myocardial
| Article | Year |
|---|---|
Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease.
Topics: Chronic Disease; Coronary Circulation; Coronary Disease; Humans; Myocardial Contraction; Myocardial | 1995 |
Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dihydropyridines; Dogs; H | 1997 |
2 other studies available for nisoldipine and Hibernation, Myocardial
| Article | Year |
|---|---|
Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow.
Topics: Animals; Blood Gas Analysis; Body Temperature; Calcium Channel Blockers; Coronary Circulation; Femal | 1996 |
Improvement of hibernation in the clinical setting.
Topics: Cardiotonic Agents; Dobutamine; Heart; Hemodynamics; Humans; Myocardial Stunning; Nisoldipine; Perfu | 1996 |